The evidence that increased levels of neutrophils (both peripheral and in primary tumors) in triple-negative and HER2-positive tumors are associated with tumor progression and dismal prognosis is indicative of a prevalent N2 phenotype in these tumors. This evidence concerns the gene ERBB2 and neoplasm.